Parkinson's disease managing reversible neurodegeneration [Corrigendum]

Hinz M, Stein A, Cole T, McDougall B, Westaway M. Neuropsychiatric Disease and Treatment. 2016;12:763–775.On page 774, Disclosure section, “MH discloses his relationship with DBS Laboratory services and NeuroResearch Clinics, Inc. The other authors report no conflicts of interest...

Full description

Bibliographic Details
Main Authors: Hinz M, Stein A, Cole T, McDougall B, Westaway M
Format: Article
Language:English
Published: Dove Medical Press 2016-06-01
Series:Neuropsychiatric Disease and Treatment
Online Access:https://www.dovepress.com/corrigendum-parkinsonrsquos-disease-managing-reversible-neuro-peer-reviewed-article-NDT
id doaj-efa130d8f10e493b89976379d6f63e5f
record_format Article
spelling doaj-efa130d8f10e493b89976379d6f63e5f2020-11-25T00:58:51ZengDove Medical PressNeuropsychiatric Disease and Treatment1178-20212016-06-012016Issue 11587158827628Parkinson's disease managing reversible neurodegeneration [Corrigendum]Hinz MStein ACole TMcDougall BWestaway MHinz M, Stein A, Cole T, McDougall B, Westaway M. Neuropsychiatric Disease and Treatment. 2016;12:763–775.On page 774, Disclosure section, “MH discloses his relationship with DBS Laboratory services and NeuroResearch Clinics, Inc. The other authors report no conflicts of interest in this work” should have been “MH discloses his relationship with DBS Laboratory services and NeuroResearch Clinics, Inc. CHK Nutrition is a subsidiary of West Duluth Distribution Co. The CEO of this company is Amy M. Gunther-Hinz and the Registered Agent is Thais M Hinz. These persons are the daughter and the wife of Dr Marty Hinz. Thais Hinz is also a shareholder of West Duluth Distribution Co. The other authors report no conflicts of interest in this work”. Read the original articlehttps://www.dovepress.com/corrigendum-parkinsonrsquos-disease-managing-reversible-neuro-peer-reviewed-article-NDT
collection DOAJ
language English
format Article
sources DOAJ
author Hinz M
Stein A
Cole T
McDougall B
Westaway M
spellingShingle Hinz M
Stein A
Cole T
McDougall B
Westaway M
Parkinson's disease managing reversible neurodegeneration [Corrigendum]
Neuropsychiatric Disease and Treatment
author_facet Hinz M
Stein A
Cole T
McDougall B
Westaway M
author_sort Hinz M
title Parkinson's disease managing reversible neurodegeneration [Corrigendum]
title_short Parkinson's disease managing reversible neurodegeneration [Corrigendum]
title_full Parkinson's disease managing reversible neurodegeneration [Corrigendum]
title_fullStr Parkinson's disease managing reversible neurodegeneration [Corrigendum]
title_full_unstemmed Parkinson's disease managing reversible neurodegeneration [Corrigendum]
title_sort parkinson's disease managing reversible neurodegeneration [corrigendum]
publisher Dove Medical Press
series Neuropsychiatric Disease and Treatment
issn 1178-2021
publishDate 2016-06-01
description Hinz M, Stein A, Cole T, McDougall B, Westaway M. Neuropsychiatric Disease and Treatment. 2016;12:763–775.On page 774, Disclosure section, “MH discloses his relationship with DBS Laboratory services and NeuroResearch Clinics, Inc. The other authors report no conflicts of interest in this work” should have been “MH discloses his relationship with DBS Laboratory services and NeuroResearch Clinics, Inc. CHK Nutrition is a subsidiary of West Duluth Distribution Co. The CEO of this company is Amy M. Gunther-Hinz and the Registered Agent is Thais M Hinz. These persons are the daughter and the wife of Dr Marty Hinz. Thais Hinz is also a shareholder of West Duluth Distribution Co. The other authors report no conflicts of interest in this work”. Read the original article
url https://www.dovepress.com/corrigendum-parkinsonrsquos-disease-managing-reversible-neuro-peer-reviewed-article-NDT
work_keys_str_mv AT hinzm parkinson39sdiseasemanagingreversibleneurodegenerationcorrigendum
AT steina parkinson39sdiseasemanagingreversibleneurodegenerationcorrigendum
AT colet parkinson39sdiseasemanagingreversibleneurodegenerationcorrigendum
AT mcdougallb parkinson39sdiseasemanagingreversibleneurodegenerationcorrigendum
AT westawaym parkinson39sdiseasemanagingreversibleneurodegenerationcorrigendum
_version_ 1725220212717912064